Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

The global animal health market size is expected to reach USD 64.6 billion by 2025


LONDON, July 31, 2018 /PRNewswire/ -- Animal Health Market Size, Share & Trends Analysis Report By Animal Type, By Product (Feed Additives, Pharmaceuticals, Vaccines, Diagnostics), By Distribution Channel, By End-use, And Segment Forecasts, 2018 - 2025

Download the full report: https://www.reportbuyer.com/product/5479707

The global animal health market size is expected to reach USD 64.6 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 5.5% during the forecast period. Rapid technological advancements in veterinary care are likely to provide an upthrust to the market. For instance, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, emergence of veterinary health information systems, specifically in developed economies, is poised to help the market gain significant momentum over the coming years.

With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians.Incorporation of this technology will facilitate real-time analysis of fluctuations in disease prevalence.

As a consequence of aforementioned factors, it is projected that there will be remarkable improvement in the overall penetration rate of animal health products, which is also anticipated to spur the growth of the market.

Further key findings from the report suggest:
? Vaccines are expected to exhibit a noteworthy CAGR during the forecast period due to significant increase in adoption of companion animals that demand long-term health check-ups
? The companion animal segment is estimated to expand at a higher CAGR during the same period owing to associated health benefits for humans such as lower blood pressure, greater psychological stability, and reduced anxiety attacks
? Veterinary hospitals and clinics accounted for a substantial share in 2017, owing to increasing number of hospital pharmacies coupled with high procedural volume as a consequence of frequent readmission of pets for treatment
? Retail channels and E-commerce platform commanded a sizeable cumulative share owing to factors such as high convenience associated with online pharmacies and increasing number of retail pharmacies
? Point-of-care testing is the fastest growing end-use segment due to surging demand for highly productive animals and growing investments in R&D activities for novel animal products
? In 2017, North America represented the largest share in the global animal health market owing to local presence of established pharmaceutical companies, consistently striving for extensive commercialization of their products
? Asia Pacific is expected to progress at a phenomenal CAGR due to dire clinical urgency to curb high incidence of zoonotic diseases and growing focus on management of disease outbreaks such as swine influenza and Ebola
? The key participants employ sustainability strategies, such as expanding product portfolio to gain competitive advantage. For instance, In March 2016, Merial entered into distribution agreement with Zoetis, Inc. to expand dairy product portfolio in India

Download the full report: https://www.reportbuyer.com/product/5479707

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: